ARF6: Biomarker, Therapeutic Target, and AI-Driven Precision Management for Type 2 Diabetes with Obesity
Type 2 diabetes combined with obesity is a prevalent metabolic comorbidity with high clinical heterogeneity, leading to inconsistent treatment efficacy and difficult long-term standardized management. Emerging evidence indicates that the small GTPase ADP-ribosylation factor 6 (ARF6) signaling axis plays a vital regulat...